businessbriefs
11:24in productionCh. 1 · Not a startup, but a spinoff/ 11:24 · ceiling 15 min
Strategy · Company stories

Philip Morris International

1987

PMI didn’t pivot to smoke-free—it built a regulatory firewall around Iqos while keeping cigarettes profitable.

PMI is a tobacco company formed in 1987, spun off from Altria in 2008. It makes money selling cigarettes and smoke-free products globally. Its $12.5 billion R&D spend (99% on smoke-free) and $16 billion Swedish Match acquisition built a diversified nicotine portfolio—but only Iqos has FDA authorisation as a modified risk product. Its 1990 oil-for-cigarettes deal with the Soviet state shows how it prioritises market access over infrastructure. The gap between its ‘smoke-free future’ narrative and its continued reliance on combustible cigarettes remains unaddressed.

StrategyCompany storiesAddictionBrandingCapitalismAddiction across the network →
Chapters & takeaways5
  1. 1:15
    Not a startup, but a spinoff

    PMI was not founded in 1987—it was carved out of Altria in 2008, making its 'independence' a structural separation, not an origin story.

  2. 2:36
    R&D as redirection

    Its R&D is narrowly focused: $12.5 billion spent almost entirely on smoke-free products, anchored at a dedicated Swiss centre opened in 2009.

  3. 4:10
    Regulatory first, not technical first

    FDA authorisation for Iqos in 2020 was not a scientific endorsement—it was the first—and only—MRTP approval granted to any electronic cigarette alternative.

  4. 5:59
    Acquisition as acceleration

    The $16 billion Swedish Match deal bought Zyn and scale—not innovation—bolstering PMI’s pouch and oral nicotine position after Iqos had already gained regulatory traction.

  5. 7:42
    Barter before branding

    Its 1990 oil-for-cigarettes barter with the Soviet state shows how PMI entered volatile markets via commodity swaps—not branding or infrastructure.

Worth your time?

Yes. Study the whole thing.

3.5/ 5
What works
  • Using regulatory authorisation as a competitive moat
  • Deploying acquisitions to fill portfolio gaps post-R&D
  • Entering high-risk markets through commodity barter
What does not
  • PMI's smoke-free transition reduces its dependence on nicotine addiction.
  • Zyn or Veev have FDA authorisation as modified risk tobacco products.
  • PMI was founded in 1987 as an independent entity.
Study it if
  • Students of corporate strategy under regulatory constraint
  • Analysts tracking tobacco industry adaptation
  • Researchers studying FDA MRTP pathway effects
Skip it if
  • Those seeking evidence of public health leadership
  • Investors looking for pure-play smoke-free growth
  • Policy makers expecting industry self-regulation
The written brief1 min read

What the company or idea is

Philip Morris International is a tobacco company formed in 1987, legally headquartered in Stamford, Connecticut, and operationally based in Lausanne, Switzerland. It became independent from Altria in March 2008.

How it actually makes money

PMI makes money selling cigarettes and smoke-free products—including Iqos, Zyn, and Veev—primarily outside the United States. Its revenue shifted: Iqos surpassed Marlboro in net revenue by end-2023.

What works

Its $12.5 billion R&D spend (99% on smoke-free products, 2009–2023), the Neuchâtel R&D centre opened in 2009, and the $16 billion Swedish Match acquisition in 2022 collectively expanded its non-combustible portfolio and distribution reach.

What does not

Its smoke-free transition does not reduce its dependence on nicotine addiction. It retains cigarette sales as a core revenue stream while marketing alternatives as ‘reduced-risk’—a claim validated only for Iqos by the FDA, not for Zyn or Veev.

What to take from it

PMI’s strategy reveals how incumbents use regulatory pathways—not just innovation—to redefine markets. The FDA’s MRTP authorisation for Iqos created a commercial moat no competitor has yet matched.

Is it worth your time

Yes—if you are studying how legacy industries reposition themselves under regulatory and reputational pressure, using R&D spending, acquisitions, and regulatory authorisations as strategic levers.

Same desk · Strategy4 of 134
11:50
Barrick MiningPeter Munk · 1983Barrick Mining is a gold-and-copper extraction company built through strategic acquisitions — not innovation, not discovery, not vertical integration. Its value lies in scale: 89 million ounces of gold in reserves, 3.91 million ounces produced in 2024, and a history of absorbing rivals like Placer Dome. But its governance fails where operations meet people: in 2008, Peter Munk personally silenced testimony about violence at Porgera. That gap — between reserve size and human accountability — is the real story.
11:34
Chorus Limited2011Chorus is a state-shaped infrastructure monopoly built from a 2011 demerger. It controls the physical layer of New Zealand’s internet — but not the customer relationship, pricing, or service design. Its success is measured in coverage and uptake, not profit per user or innovation. It works because regulation forces openness — not because it competes.
10:56
JBS S.A. ransomware attackJosé Batista SobrinhoJBS S.A. is the world’s largest meat processor by sales. On May 30, 2021, ransomware disabled its beef and pork slaughterhouses in the US, Canada, and Australia. It paid $11 million in Bitcoin. The White House attributed the attack to a Russian organisation; news outlets named REvil. REvil did not claim responsibility before its infrastructure vanished on July 13, 2021.
9:47
LONGi2006LONGi is the world’s largest monocrystalline silicon wafer maker. It funds rapid solar cell efficiency gains — nine appearances on the National Laboratory of the Rockies chart by April 2026 — by dominating an upstream, capital-intensive node. Its revenue jumped from $330M to $1.67B between 2013 and 2016 — all from wafers. It does not own module brands or develop solar farms. Its strength is process control, not system integration.
Up next in Business

Anglo American plc

1917 · 12:10

A century-old mining giant that cut 138,000 jobs in two years while rebranding as a green critical-minerals champion — with no evidence its new identity changes who pays or who bears the cost.

Play nextBack to Strategy
12:10